
Amid surging teen suicides, budget for in-school counseling services declines
Despite the rise in the number of suicides among Korean adolescents, existing mental health support systems continue to falter in part due to budget cuts.
While the government has rolled out emergency mental health hotlines specifically for students and established in-school counseling centers — known as 'Wee Class' — the budget for their operation has been shrinking.
The Ministry of Education's budget for Wee Classes and emergency mental health hotlines has dropped to 1.05 billion won ($774,000) in 2025 from 1.2 billion won in 2021, according to the government data.
Doubts have also been raised about the effectiveness of the system, because Wee Classes, first introduced in 2008, are a long way from being accessible for all students nationwide.
As of 2024, roughly 12,000 schools are operating in Korea. However, data also suggested that one in four of such schools do not offer mental health support.
On the other hand, teen suicides continued to surge. A total of 475 teenagers died by suicide in 2023 — a 54.7 percent increase from 307 in 2015, According to the Korean National Police Agency's data presented by Rep. Park Jeong-hyeon of the Democratic Party of Korea on Thursday.
Among middle and high school students, 42.3 percent reported experiencing significant stress, while 27.7 percent showed indications of depression.
Also, an emotional and behavioral assessment taken in 2024 by the Ministry of Education identified 17,667 students as being at risk of suicide. Including those considered vulnerable to emotional distress, over 72,000 students were flagged for additional attention.
Experts stress that preventing suicide among teenagers requires access to timely intervention and treatment, but also for the issue to be accepted as a social problem, not an individual one.
'The issue of suicide, whether that is centered around students or not, should never be perceived as a problem that only the victim had to deal with. Instead, it should be an issue that society should look back on together and ask questions such as, 'why did things have to turn out the way it did?' and 'what can we do to prevent it?,'' psychiatry professor Baek Jong-woo of Kyung Hee University told The Korea Herald.
'We need effective, stronger programs for suicide prevention and there is a need for mandatory education and counseling — especially among vulnerable groups.'
Baek added that there was also a need in dismantling academic competition.
'In an education system that makes students measure their value based on their achievements, it's easy to deprive such students of finding meaning or satisfaction in life. The system in which the students can access to seek mental health assistance — such as Wee Classes — must be made accessible for all so that help feels easier to reach.'
If you're thinking about self-harm or suicide, dial the Suicide Prevention Hotline at 109, available 24 hours a day, seven days a week. Please request a translator for English-language services.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
![[Graphic News] Americano becomes most popular drink for Korean adults](/_next/image?url=https%3A%2F%2Fwimg.heraldcorp.com%2Fnews%2Fcms%2F2025%2F07%2F02%2Fnews-p.v1.20250702.06811c5dca704b2a870ec64580865780_T1.gif&w=3840&q=100)
![[Graphic News] Americano becomes most popular drink for Korean adults](/_next/image?url=https%3A%2F%2Fall-logos-bucket.s3.amazonaws.com%2Fkoreaherald.com.png&w=48&q=75)
Korea Herald
9 hours ago
- Korea Herald
[Graphic News] Americano becomes most popular drink for Korean adults
Unsweetened coffee, especially the Americano, has become the most consumed beverage among Korean adults aged 20 and over, according to the Korea Disease Control and Prevention Agency. The survey classifies beverages as sweetened or unsweetened based on the presence of added sugar or high-fructose corn syrup. Koreans older than one year consumed an average of 274.6 grams of beverages daily as of 2023, a rise of more than 20 percent from 223.5 grams in 2019. Men averaged 300 grams per day, while women consumed 247.2 grams. People in their 30s drank the most, averaging 415.3 grams daily - more than four glasses. Unsweetened coffee, such as Americano, topped the list at 112.1 grams daily - an increase of 28.2 grams over five years. Carbonated drinks ranked second, with 48.9 grams consumed daily.


Korea Herald
a day ago
- Korea Herald
Bedridden his entire life, 11-year-old boy dies and saves 3 lives through organ donation
Kim Yeon-woo, an 11-year-old boy who spent nearly his entire life bedridden, donated his organs to three other children in need after his death on May 24, the Korea Organ Donation Agency said Wednesday. Born in May 2014 in Yongin, Gyeonggi Province, Kim began showing neurological symptoms at just one month old, when parts of his forehead and face became paralyzed after crying following a regular vaccination. Through MRI scans and other detailed examinations at a general hospital, he was found to have a serious brainstem issue that required surgical treatment. Too young to be eligible for surgery, he was expected to wait until he was eight to nine months old. However, as the paralysis spread across his entire face, he underwent emergency brain surgery at two months old. After that, he spent his days in a hospital bed, relying on a ventilator to breathe. After suffering cardiac arrest in 2019, Kim experienced a sharp decline in brain activity, and his organs soon began to lose their ability to function properly. He was pronounced brain-dead on May 24, and that same day, his family made the decision to donate his heart and both kidneys to save three other seriously ill children. 'We hoped that, through someone else's body, Yeon-woo could experience the things he never had the chance to do, like eating delicious food and laughing,' Kim's mother said. 'We truly know what it means to care for a child in pain. We sincerely hope the recipients and their families live healthy and happy lives.'


Korea Herald
2 days ago
- Korea Herald
TotalEnergies signs agreement with Daehwa Pharmaceutical in South Korea for a rooftop solar project
SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- TotalEnergies has signed a Solar Power Operating Lease Agreement with South Korean pharmaceutical company Daehwa Pharmaceutical Co., Ltd. to install a 1.8 megawatt-peak (MWp) solar photovoltaic (PV) system. The project will be implemented at Daehwa Pharmaceutical's state-of-the-art production site in Hoengseong-gun, Gangwon-do. The signing ceremony was held at Daehwa Pharmaceutical's Seoul office in the Seocho District, with key representatives from both companies in attendance. Under this 20-year agreement, TotalEnergies will fully invest in, install, operate, and maintain the solar PV system on-site at the premises of Daehwa Pharmaceutical's facilities. The system will comprise over 2,800 solar PV modules and is expected to generate approximately 2,300 megawatt-hours (MWh) of clean electricity annually, equivalent to around 20% of Daehwa Pharmaceutical's current total electricity consumption, avoiding about 1,000 tons of CO 2 emissions annually. Through this collaboration, the two companies aim to replace a portion of the factory's electricity usage with clean energy, contributing to carbon emissions reduction and promoting a sustainable energy transition in compliance with the RE100 initiative. The project is expected to begin commercial operations in the second half of 2025, following the completion of permitting and construction processes. Richard Pullen, Representative Director of TotalEnergies Renewables Projects South Korea, commented: "This agreement stands as a model case of active participation in industrial decarbonization in Korea. Based on our partnership with Daehwa Pharmaceutical, we aim to further expand our renewable energy projects across the country." Eun-Seok Kim, CEO of Daehwa Pharmaceutical, stated, "Through the adoption of this solar power system, Daehwa aims not only to reduce annual energy costs but also to take a meaningful step toward realizing environmentally friendly values by lowering carbon emissions. ESG management is no longer a choice but a necessity, and we will continue to fulfill our role as a responsible company for a sustainable future." About TotalEnergies Renewables Distributed Generation in Asia TotalEnergies Renewables Distributed Generation is a major international provider of fully integrated distributed solar energy solutions, including solar-powered rooftops, carport and ground-mounted solar power plants, with 1.5 GW of projects in construction and operation worldwide. In Asia, TotalEnergies Renewables Distributed Generation is one of the largest and fastest players in renewable energy distributed generation in the region for commercial and industrial customers, with over 200 MW of projects in operation across 10 countries. TotalEnergies and electricity TotalEnergies is building a competitive portfolio that combines renewables (solar, onshore wind, offshore wind) and flexible assets (CCGT, storage) to deliver clean firm power to its customers. As of the end of March 2025, TotalEnergies has 28 GW of installed gross renewable electricity generation capacity and aims to reach 35 GW by the end of 2025, and more than 100 TWh of net electricity production by 2030. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets energies: oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables and electricity. Our more than 100,000 employees are committed to providing as many people as possible with energy that is more reliable, more affordable and more sustainable. Active in about 120 countries, TotalEnergies places sustainability at the heart of its strategy, its projects and its operations. About Daehwa Pharmaceutical Co., Ltd., Daehwa Pharmaceutical Co., Ltd., established in 1984 and listed on KOSDAQ in 2003, is a mid-sized Korean pharmaceutical company. It was the first to be certified as an "Innovative Pharmaceutical Company" by the Ministry of Health and Welfare in 2012 and has maintained this status through five consecutive renewals, valid until 2027. The company focuses on formulation technologies such as TDDS, ODF, and improved drugs, as well as natural substance-based dementia treatments. It operates three GMP-certified plants, including a cGMP-level facility for oral anticancer drugs. Key products include oral anticancer medication (Liporaxel®), topical treatments, analgesics, and HA filler 'Amalian' from its German subsidiary. Daehwa also provides OEM manufacturing of medical patches and is committed to ESG practices with multiple ISO certifications. TotalEnergies Contact Daehwa Pharmaceutical Co., Ltd., Contact Media Relation: Jihoon Ko (jihoon@ TotalEnergies on social media Cautionary Note TotalEnergies The terms "TotalEnergies", "TotalEnergies company" or "Company" in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words "we", "us" and "our" may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies' financial results or activities is provided in the most recent Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC).